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Summary The family histories of 131 patients with histologically defined Hodgkin's disease (HD) were
studied and 2,517 first and second degree relatives and spouses were identified and followed-up. The causes of
death in deceased relatives were ascertained from death certificates. The numbers of deaths from selected
causes were compared with the numbers that would be expected if the relatives had suffered the same
mortality rates as the Scottish national population. A 4-fold increase in deaths due to HD was found among
first and second degree relatives of patients with the disease (6 cases observed compared with 1.4 expected).
Five of the 6 familial cases were related to index patients with the mixed cellularity form of the disease, the
remaining case was the brother of a patient with the lymphocyte-depleted form of the disease. The increased
risk was seen among relatives of both young and older patients and there was no consistent intrafamilial
similarity in age of onset or time of onset of disease.
The aetiology of Hodgkin's Disease (HD) is
unknown although evidence exists to implicate the
involvement of both genetic and environmental
factors. An increased risk of HD among first degree
relatives (Razis et al., 1959) and siblings
(Grufferman et al., 1977) of HD patients has been
shown. The finding of a significant association
between HD and parental consanguinity
(Abramson et al., 1978) and the results of statistical
analysis of data from a family in which several
members had HD (Thompson, 1981) suggests an
autosomal recessive HD-susceptibility gene. Case
reports of HD occurring in families with known
immunodeficiency disorders (McBride & Fenelly,
1977; Buehler et al., 1975; Harris et al., 1981) and
the suggested association between HD and certain
HLA haplotypes are consistent with the hypothesis
that inherited susceptibility to HD may be
determined by immune response genes (Marshall et
al., 1977; Bowers et al., 1977). Recent
epidemiological data suggest that HD, at least in
young people, may be a rare sequel to a common
virus infection. It has been postulated that a
decreased exposure to infections in childhood and a
later-than-average age at infection with a common
virus may predispose towards the development ofthe
disease (Gutensohn & Cole, 1981).
It is also possible that there is more than one
aetiology for the disease depending upon
histological type (Lukes et al., 1966) and age at
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onset (Cole et al., 1968; Gutensohn & Cole, 1977).
With these possibilities in mind we have
investigated the causes of death of first and second
degree relatives and spouses of patients with HD.
Materials and methods
Index cases
Two hundred and three cases of HD were identified
in the pathology records of the Dundee hospitals
for the 31-year period, 1950-1980. Nineteen cases
were excluded from the study as pathological
material was unavailable. The remaining 184 cases
were reviewed by one pathologist (J. McG.) and for
14 the original diagnosis of HD was not confirmed.
The remaining 170 cases (97 males and 73 females)
were subtyped according to the Rye classification
(Lukes et al., 1966).
Pedigrees of first and second degree relatives
were completed for 131 (71%) of these 170 patients.
The histological subtypes and ages at onset are
shown in Table I.
Pedigrees
Deceasedpatients First and second degree relatives
and spouses of decreased patients were identified
using Scottish Registration records which contain
details of all births, marriages, and deaths in
Scotland since 1855. Annual indexes are arranged
alphabetically by surname for each sex, listing the
place of registration and, from 1929 onwards, the
mother's maiden name. Sibships were assembled by
searching through the birth indexes from the year
of the parent's marriage to the year in which the
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Table I Distribution of index patients according to (a)
histologic subtype and (b) age at onset
(a) Confirmed Cases
Number
Histologic Subtype Total Studied
Nodular sclerosis 43 33
Mixed cellularity 79 61
Lymphocyte depleted 25 20
Lymphocyte predominant 18 13
Uncertain classification 5 4
TOTAL 170 131
(b) Confirmed Cases
Number
Age at Onset Total Studied
0-15 years 10 5
16-39 years 76 61
.40 years 84 65
TOTAL 170 131
mother reached the age of 50 years (in the case of
divorce or early death offspring of remarriages were
sought in the same way). The birth certificates were
then examined and identifying information (full
name and occupation of parents and date of place
of parent's marriage) was checked before including
an individual in a pedigree. The parent's marriage
certificate included their ages at marriage and their
own parent's names so that sibships in previous
generations could be compiled. Successive
generations were completed after marriages had
been identified from annual indexes (searched, for
each individual, from the age of 16-45 years).
Of the total of 118 deceased patients, 90 family
histories were successfully traced. We were unable
to establish pedigrees for 15 patients; 2 of these
patients had been adopted and the others were
patients from early in the study period when little
identifying information was available from hospital
records. A further 13 pedigrees were not compiled
because of time limitations.
Living patients Patients who were alive at the time
of the study (or their parents for 3 juvenile cases)
were interviewed either at the hospital lymphoma
clinic or in their homes. Three patients who had
moved to England were sent a questionnaire.
Details of all first and second degree relatives and
spouses were obtained including their birth dates,
occupation and, if deceased, date and cause of
death. This information was confirmed and
expanded by searching Scottish Registration records
(explained above).
Of the 52 living patients, 36 were interviewed and
3 completed questionnaires. Thirteen patients were
not interviewed either because the General
Practitioner or patient refused permission, or
because the patient had moved abroad or to an
unknown address. Of the 13, 2 pedigrees were
compiled as for deceased patients and the
remaining 11 were not included in the study.
To assess the efficacy of the procedures used to
ascertain relatives through Scottish Registration
records, we compiled 5 pedigrees of living patients
using this method, prior to interview. In all
instances the pedigrees derived were found to be at
least as complete as the family histories given by
patients themselves.
Mortality
For those relatives whose current status was
uncertain an attempt was made to trace them
through the National Health Service (NHS) Central
Register and the Department of Health and Social
Security (DHSS). Annual death indexes for
Scotland were searched also. Death certificates were
examined for all those relatives who were known,
or were found to have died, and the primary cause of
death was coded according to the 8th Revision of
the International Classification of Disease, Injury
and Causes of Death (W.H.O. Manual, 1968).
Expected numbers of deaths among relatives
were calculated by multiplying the age, sex, and
time specific person years at risk accumulated by
the study group by corresponding Scottish national
mortality rates. Person years at risk were computed
for males and females in 5-year age groups up to
the age of 84 years, years at risk after the age of 84
years were considered in one group; and in
quinquennial periods from 1911 (the first year for
which rates are given by Case et al. (1976)) up until
1981, the end of the study period (the Scottish
national mortality rates for 1976-1981 were not
readily available to us and in the calculations those
for 1970-1975 were used for this period). Person
years at risk were computed as follows: For any
siblings, children, grandchildren, aunts, uncles,
nieces and nephews of a patient, the start of the
period of risk was taken as their date of birth; for
the mother of a patient the start was taken as the
patient's date of birth and for the father as the
estimated date of conception (9 months before the
patient's date of birth); for grandmothers the risk
period was started at the date of birth of the
patient's mother (or father) and for grandfathers it
was taken to be 9 months before this date; for
spouses the risk period was started at the date of
marriage. Person years at risk prior to 1911 wereFAMILIAL HODGKIN'S DISEASE 709
ignored in the analysis as were deaths occurring
before that year.
Person years at risk were accumulated for each
individual up to date of death or emigration from
the United Kingsom, or in the case of living
individuals the date within the study period he or
she was last confirmed to be alive.
Differences between the observed and expected
numbers of deaths were tested for statistical
significance by assuming that the actual number of
deaths was sampled from a Poisson distribution
with mean equal to the expected number of deaths.
The significance tests shown are one-sided in the
direction of the observed difference.
Results
Three thousand, one hundred and twenty-eight
relatives were identified (Table II). Of these, 363
died before 1911 and have been excluded from
further analysis. A further 248 could not be
followed-up. Of the remainder, 1480 were still alive
at the time of the study, 999 had died, 22 had
emigrated from the United Kingdom, and 16 were
lost-to-follow-up.
Table III shows the number of observed and
expected deaths among relatives and spouses of the
index patients. The overall mortality rate was 86%
of that of the Scottish national death rate over the
study period. This deficit of deaths (999 deaths
against 1167.2 expected) was statistically highly
significant. The number of deaths from neoplasms
was very close to expected (186 observed against
186.1 expected) and the deficiency was due to
deaths from non-neoplastic conditions (813 against
981.1; ratio=0.83).
There were 6 deaths from HD while 1.4 were
expected. This 4-fold excess of deaths due to HD
was highly significant (P<0.01). Two of the index
cases were related and they comprise 2/6 deaths
from HD among relatives. The relationship between
these patients was not known to us before the study
was started. As the 2 cases were ascertained
independently each was counted in the analysis and
a pedigree for each of the 2 cases was constructed.
Both pedigrees were included in the computation of
person years at risk and hence in the calculation of
the expected number of cases. There were no deaths
Table II Ascertainment and follow-up of relatives of
index patients
First Second
Degree* Degree* Spouses Total
Total
ascertained 811 2217 100 3128
Death
pre 1911 36 327 0 363
Unable to be
followed-up 17 230 1 248
Total
excluded 53 557 1 611
Alive 483 923 74 1480
Dead 264 711 24 999
Emigrated 4 17 1 22
Lost to
follow-up 7 9 0 16
Total included
in analysis 758 1660 99 2517
*The definition of first and second degree relatives is
based on the proportion of genes shared in common. First
degree relatives include parents, siblings and children.
Second degree relatives include grandparents, aunts and
uncles, half-siblings, nieces and nephews and
grandchildren.
Table III Observed and expected deaths by cause in relatives of index patients
First and second
degree relatives Spouses Total
Observed Expected OIE Observed Expected OIE Observed Expected O/E
All causes 975 1136.35 0.86t 24 30.90 0.78 999 1167.25 0.86t
All neoplasms 179 179.80 1.00 7 6.32 1.11 186 186.11 1.0
Hodgkin's disease 6 1.37 4.38* 0 0.06 0 6 1.43 4.20*
Leukaemia 3 3.38 0.89 0 0.13 0 3 3.51 0.85
Causes other than
neoplasms 796 956.56 0.83t 17 24.58 0.69 813 981.10 0.83t
*P<0.01.
tP<0.001.710 KERZIN-STORRAR et al.
from HD among the spouses but only 0.06 were
expected.
There were 3 deaths from leukaemia and 3.5
were expected. In addition there were 2 deaths from
lymphomas other than HD but expected numbers
have not been calculated as national rates were not
available for this cause for the total study period.
Five of the 6 familial cases of HD occurred
among relatives of index patients whose disease was
classified histologically as mixed cellularity while
0.7 were expected (Table IV). The remaining case
was a relative of an index case with the lymphocyte
depleted form of HD.
Three of the familial cases of HD were relatives
of index patients whose disease onset was at age
<45 years and three were related to index cases
with disease onset at age >45 years (Table IV).
The excess risk was statistically significant for both
age groups.
Four of the observed cases of HD were first
degree male relatives, one was a second degree male
relative and one was a second degree female
relative. All of the index cases with affected
relatives were male (Tables IV and V).
Discussion
This study found a 4-fold increased risk of death
from HD among the first and second degree
relatives of HD patients. For various reasons it was
not possible to construct pedigrees for 39 (23%) of
the 170 index patients and 264 (8%) of the relatives
of the 131 index patients included were lost to
follow-up. We have no reason to suppose that the
persons who were successfully traced were a biased
subset with respect to their risk of HD but even if
we assume that there were no deaths from HD
among the relatives of untraced index patients and
assume all relatives were completely followed-up
the expected number of deaths would still be below
2.0, whereas 6 deaths were observed.
Previous reports of an increased familial
incidence of HD have been limited to surveys of
close relatives-either siblings (Grufferman et al.,
1977) or first degree relatives (Razis et al., 1959)-
of cases. In this study we have included all first and
second degree relatives of patients and, overall,
Table IV Observed and expected deaths due to HD in
relatives, according to (a) histologic subtype of index case,
(b) age at onset of index case and (c) first or second
degree relative
Observed Expected OIE
(a)
Nodular sclerosis 0 0.35 0
Mixed cellularity 5 0.66 7.61
Lymphocyte depleted 1 0.22 4.5
Lymphocyte predominant 0 0.10 0
Uncertain classification 0 0.04 0
(b)
Onset <45 years 3 0.75 4.0*
Onset >45 years 3 0.62 4.8*
(c)
First degree relatives 4 0.44 9.1t
Second degree relatives 2 0.93 2.2
First and second degree
relatives 6 1.37 4.40t
*P<0.05.
tP<0.01.
tP<0.001.
Table V Familial cases of HD
Index case Affected relative
Histological Age at Year of Relation to Histological Age at Year of
Sex type* onset onset Sex index patient type* death death
it M MC 25 1965 M father MC 49 1968
2t M MC 48 1964 M son MC 27 1967
3 M MC 74 1963 M father not known 59 1911
4 M MC 22 1963 M paternal not known 25 1915
grandfather
5 M MC 50 1963 F paternal not known 69 1963
aunt
6 M LD 25 1954 M brother MC 26 1952
*MC mixed cellularity; LD-lymphocyte depleted.
tlndex cases 1 and 2 are father and son.FAMILIAL HODGKIN'S DISEASE 711
have found a 4-fold excess of cases of HD, though
the excess is most marked among first degree
relatives (Table IV).
It has been suggested that HD may be 2 separate
diseases and that the form affecting young people is
aetiologically distinct from that found in older
patients (Gutensohn & Cole, 1977; 1981; Cole et
al., 1968). In the study of Grufferman et al. (1977)
the excess risk among siblings was confined to
those with disease onset below 45 years of age. The
excess among relatives of HD patients found in our
study occurred within families of patients with both
young onset and late onset disease suggesting that
familial factors influence the development of HD
regardless of age of the patient.
Previous reports of multiply affected HD families
have included cases in all of the four histological
subtypes, though there has been some suggestion
that nodular sclerosing HD is the most common
familial type (Hull & Delamore, 1978). In our study
there were only 6 cases of HD among relatives but
it is notable that none of these cases occurred in
relatives of patients with the nodular sclerosing
form of disease. Unfortunately, we do not know the
histological subtype of 3/6 cases among relatives
(Table V). The father-son pair of cases both had
disease of the mixed cellularity type. There were 5
cases in relatives of patients with the mixed
cellularity form of disease and one occurred in a
relative of an index case with the lymphocyte
depleted form. The relative, however, had the
mixed cellularity form of the disease.
The pedigrees do not suggest a simple Mendelian
pattern of inheritance. In 2 of the families the time
interval between cases (for index patients date of
onset and, for relatives, date of death) was much
greater than the difference in ages at occurrence (or
death), while in another 2 families the reverse was
true. In the fifth family 2 brothers were diagnosed
at the same age within 2 years of one another. We
calculated the observed and expected number of
cases occurring within 3 years of each other, 3-9
years, 9-15 years or more than 15 years (i.e. time
between onset of the index case and death of the
relative). For each of these time periods observed
and expected numbers were, respectively, 3, 0.17; 1,
0.30; 0, 0.26, and 2, 0.70. Thus there was some
evidence that the excess was greatest for pairs of
persons developing the disease at about the same
time. A similar comparison was made with respect
to age at developing the disease (i.e. age at onset of
the index case and age at death of the relative) and
the corresponding observed and expected numbers
were 2, 0.11 (i.e. cases with age at onset and age at
death within 3 years of each other); 0, 0.22; 1, 0.21
and 3, 0.89 (ages more than 15 years apart). Again
there was some suggestion that the excess was
greatest for pairs of persons developing the disease
F
at about the same age. It should be noted, however,
that these comparisons are based upon small
numbers of cases and the available data are not
sufficient to distinguish between shared genes or
environment as the cause of the increased incidence.
An association between familial history of cancer
and HD was found in a large retrospective study
comparing men who developed HD with their
classmates at college who did not develop the
disease (Paffenbarger et al., 1978). In the present
study there was no overall increased risk of death
due to neoplasms in relatives ofpatients with HD.
The deficit of deaths from causes other than
neoplasms (813 observed, 981.1 expected) may be
due to underascertainment of deaths in our study
group. This could have arisen if persons in the
study had died abroad or the death had not been
notified back to the NHS Central Register or to the
DHSS. If this is the explanation there is no reason
to suppose that deaths from cancer would not have
been similarly underascertained. In which case our
finding of 186 deaths from neoplasms against 186.1
expected might indicate a true excess of deaths
from cancer. This is rather a speculative suggestion,
however, as we do not know what proportion of
deaths, if any, we have failed to detect. Also it is
possible that the relatives of patients with
Hodgkin's disease are at decreased risk of death
from some non-neoplastic causes. Patients with
Hodgkin's disease tend to be of higher than average
social class (Guttensohn & Cole, 1981) and thus
their relatives might be expected to have lower than
expected mortality-though it is unlikely that this
can explain all of the deficit. We have not examined
in detail individual causes of death in the non-
neoplastic group (as mortality rates for non-
neoplastic causes are not published in summary
form from 1911 as are cancer mortality rates) but
the number of deaths from tuberculosis (31 against
38.0 expected) and bronchopneumonia (43 against
39.1 expected) were close to expectation.
In conclusion, this study documents a 4-fold
increase in risk of HD to first and second degree
relatives of affected individuals. Five of the 6
familial cases were related to index cases with the
mixed cellularity form of HD, and the relative of
the one case with the lymphocyte depleted HD had
the mixed cellularity type. The increased risk is seen
among families of both young and older onset
patients and there is no consistent intrafamilial
similarity in age of onset. No obvious common
exposure to an environmental hazard at particular
times is indicated as some of the dates of onset in
the familial cases were widely separated in time.
The number of spouses in the study was too small
to assess risk or for useful comments on the
possibility of exposure to a common relevant
environmental hazard during adult life. Although712 L. KERZIN-STORRAR et al.
finding 6/131 cases of HD to have an affected first
or second degree relative does not suggest a strong
genetic effect in HD, the distribution of cases
within families would be consistent with the
inheritance of a susceptibility gene, perhaps
operating as an inherited abnormality of the
immune response. However, the possibility that the
observed excess in families is due to common
environmental exposures cannot be ruled out.
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